Mergeomics : multidimensional data integration to identify pathogenic perturbations to biological systems

Show full item record



Shu , L , Zhao , Y , Kurt , Z , Byars , S G , Tukiainen , T , Kettunen , J , Orozco , L D , Pellegrini , M , Lusis , A J , Ripatti , S , Zhang , B , Inouye , M , Makinen , V-P & Yang , X 2016 , ' Mergeomics : multidimensional data integration to identify pathogenic perturbations to biological systems ' , BMC Genomics , vol. 17 , 874 .

Title: Mergeomics : multidimensional data integration to identify pathogenic perturbations to biological systems
Author: Shu, Le; Zhao, Yuqi; Kurt, Zeyneb; Byars, Sean Geoffrey; Tukiainen, Taru; Kettunen, Johannes; Orozco, Luz D.; Pellegrini, Matteo; Lusis, Aldons J.; Ripatti, Samuli; Zhang, Bin; Inouye, Michael; Makinen, Ville-Petteri; Yang, Xia
Contributor organization: Institute for Molecular Medicine Finland
Samuli Olli Ripatti / Principal Investigator
Biostatistics Helsinki
Complex Disease Genetics
Date: 2016-11-04
Language: eng
Number of pages: 16
Belongs to series: BMC Genomics
ISSN: 1471-2164
Abstract: Background: Complex diseases are characterized by multiple subtle perturbations to biological processes. New omics platforms can detect these perturbations, but translating the diverse molecular and statistical information into testable mechanistic hypotheses is challenging. Therefore, we set out to create a public tool that integrates these data across multiple datasets, platforms, study designs and species in order to detect the most promising targets for further mechanistic studies. Results: We developed Mergeomics, a computational pipeline consisting of independent modules that 1) leverage multi-omics association data to identify biological processes that are perturbed in disease, and 2) overlay the disease-associated processes onto molecular interaction networks to pinpoint hubs as potential key regulators. Unlike existing tools that are mostly dedicated to specific data type or settings, the Mergeomics pipeline accepts and integrates datasets across platforms, data types and species. We optimized and evaluated the performance of Mergeomics using simulation and multiple independent datasets, and benchmarked the results against alternative methods. We also demonstrate the versatility of Mergeomics in two case studies that include genome-wide, epigenome-wide and transcriptome-wide datasets from human and mouse studies of total cholesterol and fasting glucose. In both cases, the Mergeomics pipeline provided statistical and contextual evidence to prioritize further investigations in the wet lab. The software implementation of Mergeomics is freely available as a Bioconductor R package. Conclusion: Mergeomics is a flexible and robust computational pipeline for multidimensional data integration. It outperforms existing tools, and is easily applicable to datasets from different studies, species and omics data types for the study of complex traits.
Subject: Mergeomics
Integrative genomics
Multidimensional data integration
Functional genomics
Gene networks
Key drivers
Blood glucose
3111 Biomedicine
Peer reviewed: Yes
Rights: cc_by
Usage restriction: openAccess
Self-archived version: publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
art_3A10.1186_2Fs12864_016_3198_9.pdf 1.758Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record